# Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide

> **NCT00632853** · PHASE3 · UNKNOWN · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 731 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **RADIATION:** Standard Radiation Dose Therapy
- **DRUG:** cisplatin
- **DRUG:** etoposide
- **RADIATION:** High Radiation Dose Therapy
- **DRUG:** carboplatin

## Key facts

- **NCT ID:** NCT00632853
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-03
- **Primary completion:** 2022-03-02
- **Final completion:** —
- **Target enrollment:** 731 (ACTUAL)
- **Last updated:** 2023-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00632853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00632853, "Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00632853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*